Skip Navigation


Mol. Hum. Reprod. Advance Access originally published online on May 7, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
10/7/495    most recent
gah069v2
gah069v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Classen-Linke, I.
Right arrow Articles by von Rango, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Classen-Linke, I.
Right arrow Articles by von Rango, U.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 10, No. 7, pp. 495-504, 2004
Molecular Human Reproduction vol. 10 no. 7 © European Society of Human Reproduction and Embryology 2004; all rights reserved

The cytokine receptor gp130 and its soluble form are under hormonal control in human endometrium and decidua

I. Classen-Linke3,1, G. Müller-Newen2, P.C. Heinrich2, H.M. Beier1 and U. von Rango1

1Department of Anatomy and Reproductive Biology, RWTH University of Aachen, Wendlingweg 2, 52057 Aachen, Germany 2Department of Biochemistry, RWTH University of Aachen, Pauwelsstraße 30, 52057 Aachen, Germany

3 To whom correspondence should be addressed.; Email: iclassen-linke{at}ukaachen.de

The transmembrane protein gp130 plays a central role in cytokine action as a signal transducing receptor subunit common to all interleukin-6 type cytokines. Endometrial tissue obtained from women with a normal menstrual cycle and decidua obtained from women in the first or second trimester of pregnancy were assessed for gp130 by western blotting, immunohistochemistry and enzyme-linked immunosorbent assay (ELISA) analysis. By immunoblotting, two forms of gp130 were detected: one—the soluble form—of ~100 kDa and a larger membrane-bound form of ~150 kDa. The latter became clearly visible in the mid to late secretory phase and was more pronounced in decidual tissue of second trimester compared to first trimester. Immunohistochemically, gp130 was located in glandular epithelial cells during the mid to late secretory phase, whereas staining in the proliferative phase was rather weak. In first and second trimester decidua, glandular cells were also positively stained. In addition, the invading trophoblast cells were gp130 positive. Soluble gp130 release was measured in the supernatants from primary endometrial and decidual cell cultures by ELISA and reached maximum values in cell cultures without addition of hormones. In cultured endometrial epithelial cells obtained during the proliferative phase of the cycle, the soluble gp130 release increased significantly under combined estradiol/progesterone supplementation which mimics the secretory phase conditions compared to estradiol supplementation alone. In cultured epithelial cells derived from decidual tissue of first trimester of pregnancy, similar effects of hormonal regulation were observed. Our results suggest that the balance between soluble gp130 and its membrane-bound form may play an important role in regulating cytokine action necessary for blastocyst implantation and for further interaction between the decidualized endometrium and the invading trophoblast.

Key words: human endometrium/decidua/soluble gp130/IL-6 type cytokines


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
I. H. Cook, J. Evans, D. Maldonado-Perez, H. O. Critchley, K. J. Sales, and H. N. Jabbour
Prokineticin-1 (PROK1) modulates interleukin (IL)-11 expression via prokineticin receptor 1 (PROKR1) and the calcineurin/NFAT signalling pathway
Mol. Hum. Reprod., March 1, 2010; 16(3): 158 - 169.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
T. Ding, H. Song, X. Wang, A. Khatua, and B. C Paria
Leukemia inhibitory factor ligand-receptor signaling is important for uterine receptivity and implantation in golden hamsters (Mesocricetus auratus)
Reproduction, January 1, 2008; 135(1): 41 - 53.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
K. Wanggren, P.G. Lalitkumar, F. Hambiliki, B. Stabi, K. Gemzell-Danielsson, and A. Stavreus-Evers
Leukaemia inhibitory factor receptor and gp130 in the human Fallopian tube and endometrium before and after mifepristone treatment and in the human preimplantation embryo
Mol. Hum. Reprod., June 1, 2007; 13(6): 391 - 397.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. R. Petty, A. L. Kindzelskii, J. Espinoza, and R. Romero
Trophoblast contact deactivates human neutrophils.
J. Immunol., March 1, 2006; 176(5): 3205 - 3214.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
E. Dimitriadis, C.A. White, R.L. Jones, and L.A. Salamonsen
Cytokines, chemokines and growth factors in endometrium related to implantation
Hum. Reprod. Update, November 1, 2005; 11(6): 613 - 630.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S. J Kimber
Leukaemia inhibitory factor in implantation and uterine biology
Reproduction, August 1, 2005; 130(2): 131 - 145.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
U. von Rango, J. Alfer, S. Kertschanska, B. Kemp, G. Muller-Newen, P.C. Heinrich, H.M. Beier, and I. Classen-Linke
Interleukin-11 expression: its significance in eutopic and ectopic human implantation
Mol. Hum. Reprod., November 1, 2004; 10(11): 783 - 792.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.